Hospital Materno- Infantil de Irapuato
Irapuato, Guanajuato, 36546, Mexico
NCT Number: NCT05623553
This corss-sectional study aims to test the performance and accuracy of the Picterus JP screening device in newborns with different skin types.
Looking for future studies?
Notify Me0 day–14 day
All sexes
Interventional
Not applicable
Irapuato, Guanajuato, 36546, Mexico
A descriptive cross-sectional study among 174 newborns was carried out at Hospital Materno-Infantil de Irapuato in Mexico during July and August 2018.
The Picterus Calibration Card will be placed on the chest of the newborn with the hole in the card placed over the infant's sternum. A validated smartphone with Picterus JP will be used to collect digital images..
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use Picterus Jaundice Pro, a smartphone app that is used to take photo of the newborns skin, where the Picterus calibration card is place.
Other names: Picterus JP
Time frame: 6 months
Evaluate of smartphone-based diagnostic tool (Picterus JP) for neonatal jaundice in newborns.
Time frame: 1-2 hours
Demonstrate the correlation among the estimated levels of bilirubin obtained through a smartphone based diagnostic tool with bilirubin serum levels in a population of Mexican neonates.
Time frame: 5-10 minutes
Demonstrate the correlation among the estimated levels of bilirubin obtained through a smartphone based diagnostic tool with those obtained using a transcutaneous bilirubinometer in a population of Mexican neonates.
Time frame: 5-10 minutes
Demonstrate the correlation among the estimated levels of bilirubin obtained through a smartphone based diagnostic tool with those obtained using visual Kramer scale in a population of Mexican neonates.
Picterus AS
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06687746
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Hodal, India
View Trial DetailsNCT03741803
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Houston, Texas, United States
View Trial DetailsNCT07388732
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyper Bilirubinemia
Kütahya, Province, Turkey (Türkiye)
View Trial DetailsNCT03805165
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperbilirubinemia
Guangzhou, Guangdong, China
View Trial Details